Analysis PepsiCo’s Snack Engine Meets a New Kind of Diet: GLP-1 Drugs Reshape the Demand Map
PepsiCo investors are zeroing in on the company’s upcoming earnings release, hungry for two things above all: dependable demand signals from consumers and evidence that management is keeping a tight...